John David Finley
Director, CEO, CFO · 3 filings · Latest: Jul 6, 2026
PALISADE BIO, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PALI | John David Finley | Director, CEO, CFO | Jul 7, 2026 | Option Exercise | $0.70 | 133 | $93 | 217,688 | |
PALI | John David Finley | Director, CEO, CFO | Jul 7, 2026 | Sale | $2.07 | 146,798 | $303.3K | 217,555 | |
PALI | John David Finley | Director, CEO, CFO | Jul 6, 2026 | Option Exercise | — | 335,167 | — | 364,353 | |
PALI | Finley John David | — | Jul 7, 2026 | Proposed Sale | $2.07 | 146,798 | $303.3K | — | |
PALI | John David Finley | Director, CEO, CFO | Feb 12, 2026 | Sale | $1.75 | 3,896 | $6.8K | 27,353 | |
PALI | John David Finley | Director, CEO, CFO | Feb 11, 2026 | Option Exercise | — | 13,333 | — | 31,249 |